Diurnal Group PLC | Mutual Funds
Mutual Funds that own Diurnal Group PLC
Perpetual Income & Growth Investment Trust Plc
5,676,997
9.26%
516,316
0.79%
03/31/2018
Keystone Investment Trust Plc
1,202,977
1.96%
0
0.52%
04/30/2018
Polar Capital Funds Plc - Biotechnology Fund
1,052,632
1.72%
0
0.43%
07/31/2018
| Address |
Cardiff Medicentre
Cardiff South Glamorgan CF14 4UJ
United Kingdom
|
|
Employees
|
- |
| Website |
http://diurnal.co.uk |
| Updated |
07/08/2019 |
| Diurnal Group Plc is a specialty pharmaceutical company which addresses the unmet clinical and patient needs for hormone replacement treatments by creating products for life-long treatment for the chronic conditions, which include adrenal insufficiency, rheumatoid arthritis, hypogonadism and hypothryroidism. Its hormone therapeutics is used for proprietary formulations and novel physiological treatment regimes of approved drugs. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. |
